|
Volumn 23, Issue 6 SUPPL. 14, 1996, Pages 15-19
|
Overview of Canadian trials in hormonally resistant prostate cancer
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
MITOXANTRONE;
PREDNISONE;
PROSTATE SPECIFIC ANTIGEN;
ANALGESIA;
BONE METASTASIS;
CANADA;
CANCER HORMONE THERAPY;
CANCER PAIN;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PALLIATIVE THERAPY;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
ANTINEOPLASTIC AGENTS;
CANADA;
CLINICAL TRIALS;
HUMANS;
MALE;
MITOXANTRONE;
NEOPLASMS, HORMONE-DEPENDENT;
PALLIATIVE CARE;
PREDNISONE;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
|
EID: 0030459706
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (3)
|
References (7)
|